Targeting nrf2-mediated gene transcription by triterpenoids and their derivatives

Agnieszka Loboda1, Ewa Rojczyk-Golebiewska, Barbara Bednarczyk-Cwynar

  • 1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland.

Biomolecules & Therapeutics
|September 7, 2013
PubMed

Insights

Plant-derived triterpenoids offer chemoprevention by regulating transcription factors like Nrf2, boosting antioxidant enzymes. Synthetic analogs show promise for cancer prevention and therapy.

Area of Science:

  • Natural Products Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Chemoprevention strategies aim to protect against carcinogens.
  • Plant-derived triterpenoids, such as oleanolic acid, exhibit cytoprotective properties.
  • Transcription factors play a key role in cellular defense mechanisms.

Purpose of the Study:

  • To investigate the chemopreventive potential of plant-derived triterpenoids.
  • To explore the role of transcription factors, including Nrf2 and NF-κB, in mediating these effects.
  • To evaluate synthetic triterpenoid analogs for enhanced biological activity.

Main Methods:

  • Analysis of triterpenoid mechanisms involving transcription factor regulation (Nrf2, NF-κB).
  • Assessment of phase 2 detoxifying and antioxidant enzyme induction (NQO1, HO-1).
  • Utilizing bioinformatics and computational chemistry for synthetic analog design.
  • In vitro and in vivo experimental validation.

Main Results:

  • Triterpenoids activate the Nrf2 pathway, inducing protective enzymes like NQO1 and HO-1.
  • Inhibition of NF-κB by triterpenoids reduces pro-inflammatory gene expression.
  • Synthetic triterpenoid derivatives demonstrate improved biological properties.
  • Modulation of microRNA activity may contribute to triterpenoid efficacy.

Conclusions:

  • Plant-derived triterpenoids possess significant chemopreventive potential through Nrf2 activation and NF-κB inhibition.
  • Synthetic triterpenoids offer enhanced therapeutic prospects.
  • These compounds represent promising candidates for chemoprevention and chemotherapeutic strategies.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...